{"success":true,"data":{"pressRelease":{"id":"86746","rtpr_id":"nBw5dyC1Ha","ticker":"IPF","exchange":"LSE","all_tickers":["IPF"],"title":"REG-Qube Research & Technologies LTD Form 8.3","author":"Business Wire","published_at":"2026-07-13T14:19:00.213Z","article_body":"Form 8.3\n\n \n\nFORM 8.3\n\nPUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY\n\nA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE\n\nRule 8.3 of the Takeover Code (the “Code”)\n\n1. KEY INFORMATION\n (a) Full name of discloser: Qube Research & Technologies Limited \n (b) Owner or controller of interests and short positions disclosed, if   \n different from 1(a): \n \n \n \nThe naming of nominee or vehicle companies is insufficient. For a trust, the \n trustee(s), settlor and beneficiaries must be named. \n (c) Name of offeror/offeree in relation to whose relevant securities this form INTERNATIONAL PERSONAL FINANCE PLC \n relates: \n \n \n \nUse a separate form for each offeror/offeree \n (d) If an exempt fund manager connected with an offeror/offeree, state this   \n and specify identity of offeror/offeree: \n (e) Date position held/dealing undertaken: 10-07-2026 \n \n \n \nFor an opening position disclosure, state the latest practicable date prior to \n the disclosure \n (f) In addition to the company in 1(c) above, is the discloser making N/A \n disclosures in respect of any other party to the offer? \n \n \n \n  \n \nIf it is a cash offer or possible cash offer, state “N/A” \n\n\n2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE\n\nIf there are positions or rights to subscribe to disclose in more than one\nclass of relevant securities of the offeror or offeree named in 1(c), copy\ntable 2(a) or (b) (as appropriate) for each additional class of relevant\nsecurity.\n\n(a) Interests and short positions in the relevant securities of the offeror or\nofferee to which the disclosure relates following the dealing (if any)\n Class of relevant security: 10p ordinary \n \n \n \n  \n   Interests Short positions \n \n \n \n  \n Number % Number % \n (1) Relevant securities owned and/or controlled: 0 0.00 0 0.00 \n (2) Cash-settled derivatives: 6,617,787 2.97 0 0.00 \n \n \n \n  \n (3) Stock-settled derivatives (including options) and agreements to 0 0.00 0 0.00 \n purchase/sell: \n   6,617,787 2.97 0 0.00 \n \n \n \nTOTAL: \n\n\nAll interests and all short positions should be disclosed.\n\nDetails of any open stock-settled derivative positions (including traded\noptions), or agreements to purchase or sell relevant securities, should be\ngiven on a Supplemental Form 8 (Open Positions).\n\n(b) Rights to subscribe for new securities (including directors’ and other\nemployee options)\n Class of relevant security in relation to which subscription right exists: 0 \n Details, including nature of the rights concerned and relevant percentages: 0 \n\n\n3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE\n\nWhere there have been dealings in more than one class of relevant securities\nof the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as\nappropriate) for each additional class of relevant security dealt in.\n\nThe currency of all prices and other monetary amounts should be stated.\n\n(a) Purchases and sales\n Class of relevant security Purchase/sale Number of securities Price per unit (GBp) \n \n \n \n  \n\n\n(b) Cash-settled derivative transactions\n Class of relevant security Product description Nature of dealing Number of securities Exercise price per unit (GBp) \n \n \n \n \ne.g. call option \ne.g. opening/closing a long/short position, increasing/reducing a long/short \n position \n 10p ordinary equity swap decreasing a long position 23227 248.00 \n 10p ordinary equity swap decreasing a long position 12955 248.50 \n\n\n(c) Stock-settled derivative transactions (including options)\n\n(i) Writing, selling, purchasing or varying\n Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit (CCY0) Type Expiry date Option money paid/ received per unit \n \n \n \n \ne.g. American, European etc. \n(CCY0) \n\n\n(ii) Exercise\n Class of relevant security Product description Exercising/ exercised against Number of securities Exercise price per unit \n \n \n \ne.g. call option \n 0 0 0 0   \n \n \n \n0 \n\n\n(d) Other dealings (including subscribing for new securities)\n Class of relevant security Nature of dealing Details Price per unit (if applicable) \n \n \n \ne.g. subscription, conversion \n 0   0 0 \n \n \n \n0 \n\n\n4. OTHER INFORMATION\n\n(a) Indemnity and other dealing arrangements\n Details of any indemnity or option arrangement, or any agreement or \n understanding, formal or informal, relating to relevant securities which may \n be an inducement to deal or refrain from dealing entered into by the person \n making the disclosure and any party to the offer or any person acting in \n concert with a party to the offer: \n \n \n \nIrrevocable commitments and letters of intent should not be included. If there \n are no such agreements, arrangements or understandings, state “none” \n   \n \n \n \nNone \n \n \n \n  \n\n\n(b) Agreements, arrangements or understandings relating to options or\nderivatives\n Details of any agreement, arrangement or understanding, formal or informal, \n between the person making the disclosure and any other person relating to: \n \n \n \n(i) the voting rights of any relevant securities under any option; or \n \n \n \n(ii) the voting rights or future acquisition or disposal of any relevant \n securities to which any derivative is referenced: \n \n \n \nIf there are no such agreements, arrangements or understandings, state \n “none” \n   \n \n \n \nNone \n \n \n \n  \n\n\n(c) Attachments\n Is a Supplemental Form 8 (Open Positions) attached? YES \n\n Date of disclosure: 13-07-2026 \n Contact name: Janice Falcao \n Telephone number: 00442033140679 \n\n\nPublic disclosures under Rule 8 of the Code must be made to a Regulatory\nInformation Service.\n\nThe Panel’s Market Surveillance Unit is available for consultation in\nrelation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The\nCode can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.thetakeoverpanel.org.uk%2F&esheet=54569441&newsitemid=20260713437330&lan=en-US&anchor=www.thetakeoverpanel.org.uk&index=1&md5=7322f9f569926e74ce1843e75f19ec47)\n.\n\nSUPPLEMENTAL FORM 8 (OPEN POSITIONS)\n\nDETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS,\nAGREEMENTS TO PURCHASE OR SELL ETC.\n\nNote 5(i) on Rule 8 of the Takeover Code (the “Code”)\n\n1. KEY INFORMATION\n Full name of person making disclosure: Qube Research & Technologies Limited \n Name of offeror/offeree in relation to whose relevant securities the INTERNATIONAL PERSONAL FINANCE PLC \n disclosure relates: \n\n\n2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)\n Class of relevant security Product description e.g. call option Written or purchased Number of securities to which option or derivative relates Exercise price per unit Type Expiry date \n \n \n \ne.g. American, European etc. \n EUR 0.02 ordinary Call Option Purchased 1000 EUR 33.5 American 07/17/26 \n EUR 0.02 ordinary Put Option Purchased 400 EUR 29 American 09/18/26 \n EUR 0.02 ordinary Put Option Purchased 1400 EUR 30 American 08/21/26 \n EUR 0.02 ordinary Put Option Purchased 100 EUR 30 American 09/18/26 \n EUR 0.02 ordinary Call Option Purchased 300 EUR 32.5 American 07/17/26 \n\n\n3. AGREEMENTS TO PURCHASE OR SELL ETC.\n Full details should be given so that the nature of the interest or position \n can be fully understood: \n   \n \n \n \n  \n\n\nIt is not necessary to provide details on a Supplemental Form (Open Positions)\nwith regard to cash-settled derivatives.\n\nThe currency of all prices and other monetary amounts should be stated.\n\nThe Panel’s Market Surveillance Unit is available for consultation in\nrelation to the Code’s disclosure requirements on +44 (0)20 7638 0129.\n\nThe Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.thetakeoverpanel.org.uk%2F&esheet=54569441&newsitemid=20260713437330&lan=en-US&anchor=www.thetakeoverpanel.org.uk&index=2&md5=068256c8761b156177bb9ff170f4fddd)\n.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260713437330/en/\n(https://www.businesswire.com/news/home/20260713437330/en/)\n\nQube Research & Technologies LTD\n\n\nCopyright Business Wire 2026","article_body_html":"","raw_payload":{"data":{"id":"nBw5dyC1Ha","title":"REG-Qube Research & Technologies LTD Form 8.3","author":"Business Wire","ticker":"IPF","created":"2026-07-13T14:19:00.213Z","tickers":["IPF"],"exchange":"LSE","article_body":"Form 8.3\n\n \n\nFORM 8.3\n\nPUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY\n\nA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE\n\nRule 8.3 of the Takeover Code (the “Code”)\n\n1. KEY INFORMATION\n (a) Full name of discloser: Qube Research & Technologies Limited \n (b) Owner or controller of interests and short positions disclosed, if   \n different from 1(a): \n \n \n \nThe naming of nominee or vehicle companies is insufficient. For a trust, the \n trustee(s), settlor and beneficiaries must be named. \n (c) Name of offeror/offeree in relation to whose relevant securities this form INTERNATIONAL PERSONAL FINANCE PLC \n relates: \n \n \n \nUse a separate form for each offeror/offeree \n (d) If an exempt fund manager connected with an offeror/offeree, state this   \n and specify identity of offeror/offeree: \n (e) Date position held/dealing undertaken: 10-07-2026 \n \n \n \nFor an opening position disclosure, state the latest practicable date prior to \n the disclosure \n (f) In addition to the company in 1(c) above, is the discloser making N/A \n disclosures in respect of any other party to the offer? \n \n \n \n  \n \nIf it is a cash offer or possible cash offer, state “N/A” \n\n\n2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE\n\nIf there are positions or rights to subscribe to disclose in more than one\nclass of relevant securities of the offeror or offeree named in 1(c), copy\ntable 2(a) or (b) (as appropriate) for each additional class of relevant\nsecurity.\n\n(a) Interests and short positions in the relevant securities of the offeror or\nofferee to which the disclosure relates following the dealing (if any)\n Class of relevant security: 10p ordinary \n \n \n \n  \n   Interests Short positions \n \n \n \n  \n Number % Number % \n (1) Relevant securities owned and/or controlled: 0 0.00 0 0.00 \n (2) Cash-settled derivatives: 6,617,787 2.97 0 0.00 \n \n \n \n  \n (3) Stock-settled derivatives (including options) and agreements to 0 0.00 0 0.00 \n purchase/sell: \n   6,617,787 2.97 0 0.00 \n \n \n \nTOTAL: \n\n\nAll interests and all short positions should be disclosed.\n\nDetails of any open stock-settled derivative positions (including traded\noptions), or agreements to purchase or sell relevant securities, should be\ngiven on a Supplemental Form 8 (Open Positions).\n\n(b) Rights to subscribe for new securities (including directors’ and other\nemployee options)\n Class of relevant security in relation to which subscription right exists: 0 \n Details, including nature of the rights concerned and relevant percentages: 0 \n\n\n3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE\n\nWhere there have been dealings in more than one class of relevant securities\nof the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as\nappropriate) for each additional class of relevant security dealt in.\n\nThe currency of all prices and other monetary amounts should be stated.\n\n(a) Purchases and sales\n Class of relevant security Purchase/sale Number of securities Price per unit (GBp) \n \n \n \n  \n\n\n(b) Cash-settled derivative transactions\n Class of relevant security Product description Nature of dealing Number of securities Exercise price per unit (GBp) \n \n \n \n \ne.g. call option \ne.g. opening/closing a long/short position, increasing/reducing a long/short \n position \n 10p ordinary equity swap decreasing a long position 23227 248.00 \n 10p ordinary equity swap decreasing a long position 12955 248.50 \n\n\n(c) Stock-settled derivative transactions (including options)\n\n(i) Writing, selling, purchasing or varying\n Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit (CCY0) Type Expiry date Option money paid/ received per unit \n \n \n \n \ne.g. American, European etc. \n(CCY0) \n\n\n(ii) Exercise\n Class of relevant security Product description Exercising/ exercised against Number of securities Exercise price per unit \n \n \n \ne.g. call option \n 0 0 0 0   \n \n \n \n0 \n\n\n(d) Other dealings (including subscribing for new securities)\n Class of relevant security Nature of dealing Details Price per unit (if applicable) \n \n \n \ne.g. subscription, conversion \n 0   0 0 \n \n \n \n0 \n\n\n4. OTHER INFORMATION\n\n(a) Indemnity and other dealing arrangements\n Details of any indemnity or option arrangement, or any agreement or \n understanding, formal or informal, relating to relevant securities which may \n be an inducement to deal or refrain from dealing entered into by the person \n making the disclosure and any party to the offer or any person acting in \n concert with a party to the offer: \n \n \n \nIrrevocable commitments and letters of intent should not be included. If there \n are no such agreements, arrangements or understandings, state “none” \n   \n \n \n \nNone \n \n \n \n  \n\n\n(b) Agreements, arrangements or understandings relating to options or\nderivatives\n Details of any agreement, arrangement or understanding, formal or informal, \n between the person making the disclosure and any other person relating to: \n \n \n \n(i) the voting rights of any relevant securities under any option; or \n \n \n \n(ii) the voting rights or future acquisition or disposal of any relevant \n securities to which any derivative is referenced: \n \n \n \nIf there are no such agreements, arrangements or understandings, state \n “none” \n   \n \n \n \nNone \n \n \n \n  \n\n\n(c) Attachments\n Is a Supplemental Form 8 (Open Positions) attached? YES \n\n Date of disclosure: 13-07-2026 \n Contact name: Janice Falcao \n Telephone number: 00442033140679 \n\n\nPublic disclosures under Rule 8 of the Code must be made to a Regulatory\nInformation Service.\n\nThe Panel’s Market Surveillance Unit is available for consultation in\nrelation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The\nCode can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.thetakeoverpanel.org.uk%2F&esheet=54569441&newsitemid=20260713437330&lan=en-US&anchor=www.thetakeoverpanel.org.uk&index=1&md5=7322f9f569926e74ce1843e75f19ec47)\n.\n\nSUPPLEMENTAL FORM 8 (OPEN POSITIONS)\n\nDETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS,\nAGREEMENTS TO PURCHASE OR SELL ETC.\n\nNote 5(i) on Rule 8 of the Takeover Code (the “Code”)\n\n1. KEY INFORMATION\n Full name of person making disclosure: Qube Research & Technologies Limited \n Name of offeror/offeree in relation to whose relevant securities the INTERNATIONAL PERSONAL FINANCE PLC \n disclosure relates: \n\n\n2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)\n Class of relevant security Product description e.g. call option Written or purchased Number of securities to which option or derivative relates Exercise price per unit Type Expiry date \n \n \n \ne.g. American, European etc. \n EUR 0.02 ordinary Call Option Purchased 1000 EUR 33.5 American 07/17/26 \n EUR 0.02 ordinary Put Option Purchased 400 EUR 29 American 09/18/26 \n EUR 0.02 ordinary Put Option Purchased 1400 EUR 30 American 08/21/26 \n EUR 0.02 ordinary Put Option Purchased 100 EUR 30 American 09/18/26 \n EUR 0.02 ordinary Call Option Purchased 300 EUR 32.5 American 07/17/26 \n\n\n3. AGREEMENTS TO PURCHASE OR SELL ETC.\n Full details should be given so that the nature of the interest or position \n can be fully understood: \n   \n \n \n \n  \n\n\nIt is not necessary to provide details on a Supplemental Form (Open Positions)\nwith regard to cash-settled derivatives.\n\nThe currency of all prices and other monetary amounts should be stated.\n\nThe Panel’s Market Surveillance Unit is available for consultation in\nrelation to the Code’s disclosure requirements on +44 (0)20 7638 0129.\n\nThe Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.thetakeoverpanel.org.uk%2F&esheet=54569441&newsitemid=20260713437330&lan=en-US&anchor=www.thetakeoverpanel.org.uk&index=2&md5=068256c8761b156177bb9ff170f4fddd)\n.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260713437330/en/\n(https://www.businesswire.com/news/home/20260713437330/en/)\n\nQube Research & Technologies LTD\n\n\nCopyright Business Wire 2026"},"type":"article","timestamp":"2026-07-13T14:19:00.305631229Z","server_sent_at_ms":1783952340305},"received_at":"2026-07-13T14:19:00.455Z","source_url":"https://www.businesswire.com/news/home/20260713437330/en/"},"analysis":{"id":"75809","press_release_id":"86746","analysis_json":{"industry":{"label":"Consumer Finance","sector":"Financials"},"redFlags":[],"eventType":"insider_transaction","narrative":"Qube Research & Technologies disclosed a reduction in its long position in International Personal Finance, citing a decrease in its cash-settled derivatives holdings.\n\nThe firm sold a total of 36,182 securities via equity swaps at prices between 248.00p and 248.50p per share on July 10, 2026.\n\nFollowing these transactions, Qube retains a long interest of 6,617,787 shares, representing 2.97% of the company's relevant securities.","sentiment":"bearish","agentHooks":{"shouldPost":false,"suggestedAngle":"Minor trim by Qube Research via equity swaps."},"keyFigures":{"customDimensions":{"price_range_gb":"248.00p - 248.50p","holding_percent":"2.97%","total_long_derivatives":6617787}},"quotedText":"","namedEntities":{"people":[{"name":"Janice Falcao","role":"Contact"}],"products":[],"companies":[{"name":"Qube Research & Technologies Limited","relationship":"1%+ holder / discloser"},{"name":"INTERNATIONAL PERSONAL FINANCE PLC","ticker":"IPF","relationship":"offeree / issuer"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Routine Rule 8.3 disclosure detailing a minor reduction in a long derivatives position by a 1%+ holder; no material shift in control or strategy."},"tickerRelevance":{"others":[],"primary":"IPF"},"globalImportance":10,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"mid_cap_uk","eventGravity":"routine_8.3_filing","marketCapAdjustment":"low"}},"event_type":"insider_transaction","event_type_secondary":null,"sentiment":"bearish","material_impact_score":1,"narrative":"Qube Research & Technologies disclosed a reduction in its long position in International Personal Finance, citing a decrease in its cash-settled derivatives holdings.\n\nThe firm sold a total of 36,182 securities via equity swaps at prices between 248.00p and 248.50p per share on July 10, 2026.\n\nFollowing these transactions, Qube retains a long interest of 6,617,787 shares, representing 2.97% of the company's relevant securities.","key_figures":{"customDimensions":{"price_range_gb":"248.00p - 248.50p","holding_percent":"2.97%","total_long_derivatives":6617787}},"named_entities":{"people":[{"name":"Janice Falcao","role":"Contact"}],"products":[],"companies":[{"name":"Qube Research & Technologies Limited","relationship":"1%+ holder / discloser"},{"name":"INTERNATIONAL PERSONAL FINANCE PLC","ticker":"IPF","relationship":"offeree / issuer"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-07-13T16:14:00.570Z","global_importance":10,"audience_relevance":10,"importance_components":{"tickerTier":"mid_cap_uk","eventGravity":"routine_8.3_filing","marketCapAdjustment":"low"}},"durationMs":177561,"modelName":"glm-4.7"}}